Predictive factors of efficacy of combination therapy with basal insulin and liraglutide in type 2 diabetes when switched from longstanding basal-bolus insulin: Association between the responses of β- and α-cells to GLP-1 stimulation and the glycaemic control at 6 months after switching therapy-Reference-Cited by-同舟云学术

Predictive factors of efficacy of combination therapy with basal insulin and liraglutide in type 2 diabetes when switched from longstanding basal-bolus insulin: Association between the responses of β- and α-cells to GLP-1 stimulation and the glycaemic control at 6 months after switching therapy

Published:2018-10 Issue: Volume:144 Page:161-170
ISSN:0168-8227
Container-title:Diabetes Research and Clinical Practice
language:en
Short-container-title:Diabetes Research and Clinical Practice

Author:

Horie Ichiro,Haraguchi Ai,Sako Ayaka,Akeshima Junya,Niri Tetsuro,Shigeno Riyoko,Ito Ayako,Nozaki Aya,Natsuda Shoko,Akazawa Satoru,Mori Yoshitaka,Ando Takao,Kawakami Atsushi,Abiru Norio

Publisher

Elsevier BV

Subject

Endocrinology,General Medicine,Endocrinology, Diabetes and Metabolism,Internal Medicine

Reference31 articles.

1. The beta cell lesion in type 2 diabetes: there has to be a primary functional abnormality;Kahn;Diabetologia,2009

2. pharmacologic approaches to glycemic treatment: standards of medical care in diabetes-2018;American Diabetes Association;Diabetes Care,2018

3. GLP-1 receptor agonists for individualized treatment of type 2 diabetes mellitus;Meier;Nat Rev Endocrinol,2012

4. Glucagon-like peptide-1 receptor agonist and basal insulin combination treatment for the management of type 2 diabetes: a systematic review and meta-analysis;Eng;Lancet,2014

5. Management of hyperglycemia in type 2 diabetes, 2015: a patient-centered approach: update to a position statement of the American Diabetes Association and the European Association for the Study of Diabetes;Inzucchi;Diabetes Care,2015

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. De-Intensification from Basal-Bolus Insulin Therapy to Liraglutide in Type 2 Diabetes: Predictive Value of Mean Glycaemia during Fasting Test;Life;2024-04-28

2. Transitioning from basal–bolus or premix insulin therapy to a combination of basal insulin and glucagon‐like peptide‐1 receptor agonist in people with type 2 diabetes;Diabetic Medicine;2022-06-26

3. Liraglutide Alleviates Hepatic Steatosis and Liver Injury in T2MD Rats via a GLP-1R Dependent AMPK Pathway;Frontiers in Pharmacology;2021-03-04

4. Type II diabetes mellitus: a review on recent drug based therapeutics;Biomedicine & Pharmacotherapy;2020-11

5. New Medications for the Treatment of Diabetes;Diabetes Technology & Therapeutics;2020-02-01